Roberto Iacone
Director Ejecutivo en Alentis Therapeutics AG .
Perfil
Roberto Iacone is the founder of Bright Peak Therapeutics AG, Ridgeline Therapeutics.
He is currently the Chief Executive Officer & Director at Alentis Therapeutics AG and a Venture Partner at Pureos Partners AG.
Dr. Iacone holds a doctorate degree from Università degli Studi di Napoli Federico II.
Cargos activos de Roberto Iacone
Empresas | Cargo | Inicio |
---|---|---|
Alentis Therapeutics AG
Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Director Ejecutivo | 29/07/2020 |
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Inversor de Capital Privado | - |
Antiguos cargos conocidos de Roberto Iacone.
Empresas | Cargo | Fin |
---|---|---|
Ridgeline Therapeutics | Fundador | - |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Head-Fixed Income Invts | - |
Formación de Roberto Iacone.
Università degli Studi di Napoli Federico II | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Alentis Therapeutics AG
Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Health Technology |
Ridgeline Therapeutics | |
Pureos Partners AG
Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Finance |
- Bolsa de valores
- Insiders
- Roberto Iacone